BostonGene Tumor Portrait™ Tests

BostonGene Tumor Portrait™ Tests, based on integrated genomic and transcriptomic analysis, propel precision medicine into daily clinical practice and supports physicians in actualizing personalized therapy for cancer patients.

BostonGene integrated genomic and transcriptomic analysis, in concert with the patient’s clinical history, provides information regarding the likely benefits of therapies or therapeutic combinations, suitable NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) treatment recommendations and ongoing clinical trials.

The BostonGene Tumor Portrait™ test combines precise data-processing and proprietary algorithms to generate easy-to-understand tumor schematics, the Molecular Functional Portrait™ (Cancer Cell, 2021 Jun 14;39(6):845-865.e7).

The BostonGene Tumor Portrait™ test directly depicts tumor cellular composition, microenvironment composition, immune activity, and other tumor activating or suppressing processes. BostonGene integrated model of tumor genetics, transcriptomics, microenvironment and tumor composition provides a 360° overview of a patient tumor to give medical professionals invaluable insights into potential treatment options.

HOW TO START

BostonGene works directly with oncologists, care teams, surgeons and pathologists to assist with every step of the process from test request placement to request delivery. We provide kits that include everything you need for specimen collection and shipping.

Please contact us to learn more about BostonGene tests, order kits or obtain information about clinical trial solutions.

SAMPLE REQUIREMENTS

BostonGene requires normal (blood or saliva) and tumor specimens accepting Formalin-Fixed Paraffin-Embedded (FFPE) or fresh/fresh frozen (FF) tissue.

BOSTONGENE CAP/CLIA LABORATORY

Analysis are performed in the BostonGene Laboratory that is certified under the Clinical Laboratory Improvement Amendments (CLIA) and accredited by the College of American Pathologists (CAP) as qualified to perform high complexity clinical laboratory testing.

BostonGene tests focused on individual cancer types provide findings relevant for a patient disease.

SOLID CANCERS

Adrenocortical Cancer

Breast Cancer

Cervical Cancer

Cutaneous Melanoma

CNS Cancer

Colorectal Cancer

Esophageal Cancer

Endometrial Cancer

Glioblastoma

Gastric Cancer

Head and Neck Cancer

Kidney Cancer

Liver Cancer

NSCLC

Ovarian Cancer

Pancreatic Cancer

Prostate Cancer

Sarcomas

Rare Cancers

Thyroid Cancer

Urothelial and Bladder Cancer

Unknown Origin Cancers

HEMATOLOGIC CANCERS

Acute Myeloid Leukemia

Chronic Lymphocytic Leukemia

Diffuse Large B-Cell Lymphoma

Follicular Lymphoma

High-Grade Lymphoma

Mantle Cell Lymphoma

Multiple Myeloma

Peripheral T-Cell Lymphoma